Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial. - Petersenn S; Salgado LR; Schopohl J; Portocarrero-Ortiz L; Arnaldi G; Lacroix A; Scaroni C; Ravichandran S; Kandra A; Biller BMK (Endocrine, 2017)